A Phase II, Multicenter Study of Lazertinib as Consolidation Therapy in Patients with Locally Advanced, Unresectable, EGFR Mutation positive Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based, Chemoradiation Therapy (PLATINUM Trial)
Lazertinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase II, Multicenter Study of Lazertinib as Consolidation Therapy in Patients with Locally Advanced, Unresectable, EGFR Mutation positive Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based, Chemoradiation Therapy (PLATINUM Trial) ### Output: Lazertinib